These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17765378

  • 1. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):150-4. PubMed ID: 17765378
    [Abstract] [Full Text] [Related]

  • 2. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Clin Neuropharmacol; 2009 Jan 01; 32(1):6-9. PubMed ID: 19471183
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):881-5. PubMed ID: 18243460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An open trial of valproate in borderline personality disorder.
    Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.
    J Clin Psychiatry; 1995 Nov 01; 56(11):506-10. PubMed ID: 7592502
    [Abstract] [Full Text] [Related]

  • 9. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.
    Teicher MH, Glod CA, Aaronson ST, Gunter PA, Schatzberg AF, Cole JO.
    Psychopharmacol Bull; 1989 Nov 01; 25(4):535-49. PubMed ID: 2631134
    [Abstract] [Full Text] [Related]

  • 10. [Long-acting injectable risperidone in treatment resistant borderline personality disorder. A small series report].
    Díaz-Marsá M, Galian M, Montes A, Fernández R, Arza R, López-Ibor J, Carrasco J.
    Actas Esp Psiquiatr; 2008 Nov 01; 36(2):70-4. PubMed ID: 18365787
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S, Paradiso E, Bogetto F.
    Psychiatry Res; 2008 Nov 30; 161(2):206-12. PubMed ID: 18848360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A relationship between bipolar II disorder and borderline personality disorder?
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May 15; 32(4):1022-9. PubMed ID: 18313825
    [Abstract] [Full Text] [Related]

  • 14. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.
    Golubchik P, Sever J, Zalsman G, Weizman A.
    Int Clin Psychopharmacol; 2008 Jul 15; 23(4):228-31. PubMed ID: 18446088
    [Abstract] [Full Text] [Related]

  • 15. Fluoxetine trial in borderline personality disorder.
    Cornelius JR, Soloff PH, Perel JM, Ulrich RF.
    Psychopharmacol Bull; 1990 Jul 15; 26(1):151-4. PubMed ID: 2371370
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.
    J Clin Psychopharmacol; 2008 Apr 15; 28(2):147-55. PubMed ID: 18344724
    [Abstract] [Full Text] [Related]

  • 17. Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder.
    Carpiniello B, Lai L, Pirarba S, Sardu C, Pinna F.
    Psychiatry Res; 2011 Jun 30; 188(1):40-4. PubMed ID: 21131058
    [Abstract] [Full Text] [Related]

  • 18. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
    Roepke S, Merkl A, Dams A, Ziegenhorn A, Anghelescu IG, Heuser I, Lammers CH.
    Pharmacopsychiatry; 2008 Sep 30; 41(5):176-81. PubMed ID: 18763219
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E, Lemelin S.
    J Clin Psychiatry; 2005 Oct 30; 66(10):1298-303. PubMed ID: 16259544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.